research use only
Cat.No.S1525
| Related Targets | CDK HSP PD-1/PD-L1 ROCK DNA/RNA Synthesis Microtubule Associated Ras KRas Aurora Kinase Casein Kinase |
|---|---|
| Other Wee1 Inhibitors | PD0166285 Zedoresertib (Debio-0123, WEE1-IN-5) Azenosertib (Zn-C3) BMS-986463 Potrasertib |
|
In vitro |
DMSO
: 100 mg/mL
(199.76 mM)
Water : Insoluble Ethanol : Insoluble The solubility data above are all experimental results (not literature values). |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
Read more about Adavosertib (AZD1775, MK-1775) solubility in DMSO or water
Read more about Adavosertib (AZD1775, MK-1775) working concentrations for cell culture treatment
Adavosertib (AZD1775, MK-1775) is a potent inhibitor of Wee1 kinase (5.2 nmol/L), CYP3A (14 μM), and pCDK1 (240 nmol/L). Adavosertib (AZD1775, MK-1775) exhibits the greatest inhibitory potency toward Wee1 kinase (IC50 = 5.2 nM).
| Information | Adavosertib is a potent, selective ATP-competitive Wee1 inhibitor. It affects cell cycle and DNA damage response signaling by reducing CDK1 phosphorylation and abrogating the G2/M checkpoint, effectively inhibiting tumor cell proliferation and promoting apoptosis. |
|---|---|
|
Read more about Adavosertib (AZD1775, MK-1775) IC50 for cell-based and cell-free assays |
|
| Primary Applications and Mechanism of Action | |
Read more about Adavosertib (AZD1775, MK-1775) Mechanism of Action
| Molecular Weight | 500.6 | Formula | C27H32N8O2 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 955365-80-7 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | AZD1775 | Smiles | CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O | ||
Read more comparative analysis about Adavosertib (AZD1775, MK-1775)
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.
Question 1:
How to prepare its methylcellulose solution? and how to prepare methylcellulose itself? Once make the solution, how should i keep it?
Answer:
It is a suspension or emulsion in 0.5% methylcellulose, and it is ok to treat mice orally. It is recommended to dissolve methylcellulose in saline. It will take some time to dissolve methylcellulose, and you can vortex it for a while. The methylcellulose solution of this compound can be stored at 4°C for a week.